400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2500104800
正在进行
/
/
/
2025-06-24
/
/
Cholelithiasis
Randomized Control Trial on Effectiveness and Safety of Direct Trocar versus Veress Needle Entry Techniques in Obese Women During Laparoscopic Cholecystectomy
Randomized Control Trial on Effectiveness and Safety of Direct Trocar versus Veress Needle Entry Techniques in Obese Women During Laparoscopic Cholecystectomy
To compare the outcomes of direct trocar versus Veress needle entry techniques in obese women during laparoscopic cholecystectomy.
随机平行对照
Ⅰ期
The patients will be divided into two equal groups by using lottery method.
Not stated
/
/
90
/
2025-07-01
2026-03-31
/
Obese women with body mass index >= 30 kg/m^2, having cholelithiasis, with an American society of Anesthesiology (ASA) status I and II will be included.;
请登录查看Men, non-obese women, Patients who had previous history of abdominal surgery, ASA status ≥ III, clinically obvious ongoing infection, those having poorly controlled type 2 diabetes mellitus, other comorbid conditions like hypertension and chronic renal failure, concomitant cardiopulmonary severe disease, abnormalities with the clotting/bleeding and the patients who are unfit to undergo general anesthesia.;
请登录查看Combine Military Hospital Quetta
/
英百瑞生物2025-12-05
艾力斯医药科技2025-12-05
神曦生物NeuExcell2025-12-05
科望医药2025-12-05
宠药生态圈2025-12-05
丁香园 Insight 数据库2025-12-05
佰傲谷BioValley2025-12-05
药精通Bio2025-12-05
医药观澜2025-12-05
贝达药业2025-12-05